Development and validation of prediction models for mechanical ventilation, renal replacement therapy, and readmission in COVID-19 patients

Author:

Rodriguez Victor Alfonso1,Bhave Shreyas1,Chen RuijunORCID,Pang Chao12,Hripcsak George1,Sengupta Soumitra1,Elhadad Noemie1,Green Robert3,Adelman Jason4,Metitiri Katherine Schlosser5,Elias Pierre1,Groves Holden6,Mohan Sumit7,Natarajan Karthik1ORCID,Perotte Adler1

Affiliation:

1. Department of Biomedical Informatics, Columbia University, New York, New York, USA

2. Department of Translational Data Science and Informatics, Geisinger, Danville, Pennsylvania, USA

3. Department of Emergency Medicine, Columbia University Irving Medical Center, New York, New York, USA

4. Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA

5. Department of Pediatrics, Columbia University Irving Medical Center, New York, New York, USA

6. Department of Anesthesiology, Columbia University Irving Medical Center, New York, New York, USA

7. Division of Nephrology, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA

Abstract

Abstract Objective Coronavirus disease 2019 (COVID-19) patients are at risk for resource-intensive outcomes including mechanical ventilation (MV), renal replacement therapy (RRT), and readmission. Accurate outcome prognostication could facilitate hospital resource allocation. We develop and validate predictive models for each outcome using retrospective electronic health record data for COVID-19 patients treated between March 2 and May 6, 2020. Materials and Methods For each outcome, we trained 3 classes of prediction models using clinical data for a cohort of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)–positive patients (n = 2256). Cross-validation was used to select the best-performing models per the areas under the receiver-operating characteristic and precision-recall curves. Models were validated using a held-out cohort (n = 855). We measured each model’s calibration and evaluated feature importances to interpret model output. Results The predictive performance for our selected models on the held-out cohort was as follows: area under the receiver-operating characteristic curve—MV 0.743 (95% CI, 0.682-0.812), RRT 0.847 (95% CI, 0.772-0.936), readmission 0.871 (95% CI, 0.830-0.917); area under the precision-recall curve—MV 0.137 (95% CI, 0.047-0.175), RRT 0.325 (95% CI, 0.117-0.497), readmission 0.504 (95% CI, 0.388-0.604). Predictions were well calibrated, and the most important features within each model were consistent with clinical intuition. Discussion Our models produce performant, well-calibrated, and interpretable predictions for COVID-19 patients at risk for the target outcomes. They demonstrate the potential to accurately estimate outcome prognosis in resource-constrained care sites managing COVID-19 patients. Conclusions We develop and validate prognostic models targeting MV, RRT, and readmission for hospitalized COVID-19 patients which produce accurate, interpretable predictions. Additional external validation studies are needed to further verify the generalizability of our results.

Funder

National Institutes of Health

National Library of Medicine

NIH

NLM

National Heart, Lung, and Blood Institute

Publisher

Oxford University Press (OUP)

Subject

Health Informatics

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3